1. Home >
  2. M&A >
  3. Divestiture >
  4. Japan >
  5. Mitsui & Co Acquires Sumitomo Pharma AH

M&A Deal Summary

Mitsui & Co Acquires Sumitomo Pharma AH

On December 26, 2022, Mitsui & Co acquired consumer services company Sumitomo Pharma AH from Sumitomo Pharma

Acquisition Highlights
  • This is Mitsui & Co’s 1st transaction in the Consumer Services sector.
  • This is Mitsui & Co’s 6th transaction in Japan.

M&A Deal Summary
Date 2022-12-26
Target Sumitomo Pharma AH
Sector Consumer Services
Buyer(s) Mitsui & Co
Sellers(s) Sumitomo Pharma
Deal Type Divestiture

Target

Sumitomo Pharma AH

Osaka, Japan
Sumitomo Pharma AH is a Japanese animal health company that leverages its advanced product development capabilities accumulated as a subsidiary of a pharmaceutical manufacturer to develop, manufacture, and sell veterinary medicines for companion animals and livestock, especially in Japan. Sumitomo Pharma AH is based in Osaka, Japan.

Search 205,528 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Mitsui & Co

Tokyo, Japan
Category Company
Founded 1947
Sector Diversified
Employees53,602
Revenue 13.32T JPY (2024)
DESCRIPTION

Mitsui & Co engages in the export, import, wholesale, and retail of steel products; steel processing; mining and sale of iron ores; and sale and trading of ferrous scrap and alloy products and chemicals, energy, food, food & retail management, healthcare & service, consumer business, IT & communication business, corporate development business. Mitsui & Co was founded in 1947 and is based in Tokyo, Japan.

DEAL STATS #
Overall 39 of 47
Sector (Consumer Services) 1 of 2
Type (Divestiture) 2 of 2
Country (Japan) 6 of 6
Year (2022) 6 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-07 Lokavant

New York, New York, United States

Lokavant is a clinical intelligence platform that improves the time, cost, and quality of trial planning and execution through data-driven analytics applications. Lokavant's platform aggregates and integrates real-time data from disparate trial data sources, and powers advanced analytics enabled by its compendium of proprietary trial data. Lokavant was founded in 2020 and is based in New York City.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-06-08 Spaceflight

Seattle, Washington, United States

Spaceflight is a next-generation space product and launch services company. Spaceflight offers global launch opportunities, along with comprehensive launch and integration services. Spaceflight is based in Seattle, Washington.

Sell -

Seller(S) 1

SELLER

Sumitomo Pharma

Osaka, Japan
Category Company
Founded 1897
Sector Life Science
Employees4,980
Revenue 314.6B JPY (2024)
DESCRIPTION

Sumitomo Pharma is a pharmaceutical and life science company. Sumitomo Pharma was founded in 1897 and is based in Osaka, Japan.

DEAL STATS #
Overall 1 of 1
Sector (Consumer Services) 1 of 1
Type (Divestiture) 1 of 1
Country (Japan) 1 of 1
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-09-03 Sunovion Pharmaceuticals.

Marlborough, Massachusetts, United States

Sunovion is a pharmaceutical company dedicated to discovering, developing and commercializing therapeutic products that advance the science of medicine in the central nervous system (CNS) and respiratory disease areas and improve the lives of patients and their families.

Buy $2.6B
Mergr

Product

Company

Legal